Rigel Pharmaceuticals (RIGL) Return on Assets (2011 - 2026)
Rigel Pharmaceuticals (RIGL) posted quarterly Return on Assets of 0.01% for Q1 2026, little changed year-over-year from 0.01% in Q1 2025, and down 26.3% quarter-over-quarter from 0.01% in Q4 2025.
Rigel Pharmaceuticals (RIGL) Return on Assets (2011 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Return on Assets history runs 16 years deep, the most recent figure standing at 0.01% for Q1 2026.
- In Q1 2026, Return on Assets changed 0.0% year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 0.01% (changed 0.0% YoY), while the FY2025 annual figure was 0.01%, up 1.0% from the prior year.
- Return on Assets for Q1 2026 stood at 0.01%, down from 0.01% in the prior quarter.
- The five-year high for Return on Assets was 0.01% in Q4 2025, with the low at 0.01% in Q3 2022.
- The 5-year median for Return on Assets is 0.0% (2024), against an average of 0.0%.
- The sharpest annual moves came in 2022 and 2025: Return on Assets decreased 1 bps in 2022, then rose 1 bps in 2025.
- Rigel Pharmaceuticals' Return on Assets stood at 0.0% in 2022, then surged by 52 bps to 0.0% in 2023, then surged by 151 bps to 0.0% in 2024, then soared by 742 bps to 0.01% in 2025, then dropped by 26 bps to 0.01% in 2026.
- Business Quant data shows RIGL's Return on Assets at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.01% |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Rigel Pharmaceuticals | 795.39 Mn | 700.06 Mn | 70.18 Mn | 0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.01% |
| Mar 31, 2026 | 0.01% |
| Dec 31, 2025 | 0.01% |
| Sep 30, 2025 | 0.01% |
| Jun 30, 2025 | 0.01% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |